论文信息 - Shorter treatment for hepatitis C genotype 4 may be a possibility. - 字舞流文

Shorter treatment for hepatitis C genotype 4 may be a possibility.

S. Iqbal | M. Cerulli | M. Mansour

[1] A. el-Zayadi,et al. Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study , 2005, The American Journal of Gastroenterology.

[2] J. Izopet,et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection , 2005, Journal of medical virology.

[3] M. Al-Ahdal,et al. Peginterferon α‐2b plus ribavirin compared with interferon α‐2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4 , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[4] M. Khuroo,et al. Meta‐analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4 , 2004, Alimentary pharmacology & therapeutics.

[5] A. Neumann,et al. Slow viral dynamics of hepatitis C virus genotype 4 , 2003, Journal of viral hepatitis.